By Administrator_India Capital Sands   India’s drug regulator has given Hetero Labs and Cipla Ltd the green light to manufacture and market their generic version of Gilead Sciences Inc’s experimental COVID-19 treatment remdesivir, the Indian pharmaceutical companies said on Sunday. India’s Cipla said its generic version of remdesivir will be called Cipremi. The Drug Controller […]